Holen Sie sich die Stockscreener-App
6.48
5.95%
-0.41
Handel nachbörslich:
6.47
-0.01
-0.15%
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Walleye Capital LLC Takes Position in RxSight, Inc. $RXST - MarketBeat
Midday Stock Roundup: Staar Surgical Dips 8% After Analyst Price Cut - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? - Yahoo Finance
RxSight (RXST) Q2 2026 Earnings Call Transcript - AOL.com
(RXST) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development - AOL.com
Rxsight Inc (RXST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments - VisionMonday.com
Eye care company Alcon raises margin outlook, shares jump - marketscreener.com
Stifel cuts RxSight stock price target on competitive headwinds By Investing.com - Investing.com India
RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges - streetinsider.com
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $7.00 - MarketBeat
Stifel cuts RxSight stock price target on competitive headwinds - Investing.com
RxSight (RXST) offers to swap 4.08M underwater options for new awards - Stock Titan
Stifel Maintains RxSight(RXST.US) With Hold Rating, Cuts Target Price to $7 - Moomoo
RxSight Reports Q2 Financial Results, Provides Update on 2026 Outlook - VisionMonday.com
The RxSight, Inc. (NASDAQ:RXST) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
Wall Street Zen Upgrades RxSight (NASDAQ:RXST) to Hold - MarketBeat
Levi & Korsinsky Notifies RxSight, Inc. (RXST) InvestorsLead Plaintiff Deadline on September 22, 2025 - The National Law Review
Rxsight Inc (RXST) Stock News Today - TradingKey
A Quick Look at Today's Ratings for RxSight(RXST.US), With a Forecast Between $6 to $11 - moomoo.com
RXST|Rxsight Inc|Price:6.260|Chg%:+0.180 - TradingKey
UBS Maintains RxSight(RXST.US) With Hold Rating, Cuts Target Price to $6.3 - Moomoo
UBS Group Boosts RxSight (NASDAQ:RXST) Price Target to $6.30 - MarketBeat
Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 5 - GuruFocus
Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 519% Upside - Yahoo Finance
RxSight, Inc. Stock 12‑Month Price Target Cut to $7.91, Implies 26% Upside - TradingView
A Quick Look at Today's Ratings for RxSight(RXST.US), With a Forecast Between $9 to $11 - moomoo.com
Rxsight, Inc. Reports Second Quarter 2026 Res - Moomoo
RxSight Q2 Earnings Call Highlights - MarketBeat
RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ... - finance.yahoo.com
RxSight (NASDAQ:RXST) Releases Earnings Results, Beats Estimates By $0.22 EPS - MarketBeat
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates - finance.yahoo.com
RxSight, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
RXST: Q2 revenue was $33.7M, guidance withdrawn as business undergoes strategic reassessment - TradingView
Earnings call transcript: RxSight beats Q2 2026 estimates but withdraws guidance - Investing.com
Transcript : RxSight, Inc., Q2 2026 Earnings Call, Aug 05, 2026 - marketscreener.com
RxSight Q2 adjusted loss beats estimates; withdraws 2026 guidance - TradingView
RxSight (RXST) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
RxSight, Inc. (RXST) Tops Q2 EPS by 25c - StreetInsider
RxSight, Inc. Q2 2026: Revenue $33.74M, EPS $(0.29) — 10-Q Summary - TradingView
RxSight (NASDAQ: RXST) reports $33.7M Q2 revenue and $60M Alcon collaboration - Stock Titan
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook - The Manila Times
RXSIGHT INC Q2 ADJUSTED EPS USD -0.11 VS. IBES ESTIMATE USD -0.33 - moomoo.com
RxSight (RXST): Millennium entities, Israel Englander report 7.3% ownership stake - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
RxSight, Inc. expected to post a loss of 33 cents a shareEarnings Preview - TradingView
(RXST) Risk Channels and Responsive Allocation - Stock Traders Daily
Rxsight Inc (RXST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Healthcare of Ontario Pension Plan Trust Fund Acquires 1,000,000 Shares of RxSight, Inc. $RXST - marketbeat.com
RXST|Rxsight Inc|Price:6.295|Chg%:+0.285 - TradingKey
RxSight (RXST) Projected to Announce Quarterly Earnings on Wednesday - MarketBeat
RxSight Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
UBS Adjusts Price Target on RxSight to $5.50 From $9, Maintains Neutral Rating - marketscreener.com
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):